HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.

Abstract
Leiomyosarcoma (LMS) is a malignant tumor of smooth muscle cells for which few effective therapies exist. A subset of LMS cases express macrophage colony-stimulating factor (CSF1) and the resultant tumor-associated macrophage (TAM) infiltration predicts poor clinical outcome. Further, TAMs have been shown to increase tumor angiogenesis. Here, we analyzed 149 LMS cases by immunohistochemistry for vascular marker CD34 and show that high microvessel density (MVD) in nongynecological LMS cases significantly predicts poor patient outcome. The majority of high MVD cases were also CSF1-positive, and when combining high MVD with CSF1 expression, an even stronger prognostic correlation with patient outcome was obtained. Gene expression profiling revealed that MVD has a stronger correlation with CSF1 expression than with expression of vascular endothelial growth factor isoforms, which have traditionally been used as markers of angiogenesis and as anti-angiogenic therapeutic targets. Finally, patterns of CSF1 expression and TAM recruitment remained consistent between primary tumors and their metastases, and between primary tumors and those grown as xenografts in mice, highlighting the stability of these features to the biology of LMS tumors. Together, these findings suggest an important role for CSF1 and the resulting TAM infiltration in the pathological neovascularization of LMS tumors and provide a rationale for CSF1-targeted therapies in LMS.
AuthorsIñigo Espinosa, Badreddin Edris, Cheng-Han Lee, Hong Wei Cheng, C Blake Gilks, Yuzhuo Wang, Kelli D Montgomery, Sushama Varma, Rui Li, Robert J Marinelli, Robert B West, Torsten Nielsen, Andrew H Beck, Matt van de Rijn
JournalThe American journal of pathology (Am J Pathol) Vol. 179 Issue 4 Pg. 2100-7 (Oct 2011) ISSN: 1525-2191 [Electronic] United States
PMID21854753 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD34
  • Biomarkers, Tumor
  • Vascular Endothelial Growth Factor A
  • Macrophage Colony-Stimulating Factor
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Antigens, CD34 (metabolism)
  • Biomarkers, Tumor (metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Leiomyosarcoma (blood supply, genetics, pathology)
  • Macrophage Colony-Stimulating Factor (genetics, metabolism)
  • Macrophages (metabolism, pathology)
  • Male
  • Mice
  • Microvessels (metabolism, pathology)
  • Middle Aged
  • Neovascularization, Pathologic (metabolism, pathology)
  • Prognosis
  • Vascular Endothelial Growth Factor A (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: